HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities.

AbstractAIM:
To clarify the mechanism of the therapeutic action of icariin on erectile dysfunction (ED).
METHODS:
PDE5 was isolated from the human platelet and PDE4 from the rat liver tissue using the FPLC system (Pharmacia, Milton Keynes, UK) and the Mono Q column. The inhibitory effects of icariin on PDE5 and PDE4 activities were investigated by the two-step radioisotope procedure with [(3)H]-cGMP/[(3)H]-cAMP. Papaverine served as the control drug.
RESULTS:
Icariin and papaverine showed dose-dependent inhibitory effects on PDE5 and PDE4 activities. The IC(50) of Icariin and papaverine on PDE5 were 0.432 micromol/L and 0.680 micromol/L, respectively and those on PDE4, 73.50 micromol/L and 3.07 micromol/L, respectively. The potencies of selectivity of icariin and papaverine on PDE5 (PDE4/PDE5 of IC(50)) were 167.67 times and 4.54 times, respectively.
CONCLUSION:
Icariin is a cGMP-specific PDE5 inhibitor that may be developed into an oral effective agent for the treatment of ED.
AuthorsZ C Xin, E K Kim, C S Lin, W J Liu, L Tian, Y M Yuan, J Fu
JournalAsian journal of andrology (Asian J Androl) Vol. 5 Issue 1 Pg. 15-8 (Mar 2003) ISSN: 1008-682X [Print] China
PMID12646997 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drugs, Chinese Herbal
  • Flavonoids
  • Phosphodiesterase Inhibitors
  • Tritium
  • Papaverine
  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human
  • Pde5a protein, rat
  • Cyclic GMP
  • icariin
Topics
  • 3',5'-Cyclic-AMP Phosphodiesterases (antagonists & inhibitors, metabolism)
  • 3',5'-Cyclic-GMP Phosphodiesterases (antagonists & inhibitors, metabolism)
  • Animals
  • Cyclic AMP (metabolism)
  • Cyclic GMP (metabolism)
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Dose-Response Relationship, Drug
  • Drugs, Chinese Herbal (pharmacology)
  • Flavonoids (pharmacology)
  • Humans
  • In Vitro Techniques
  • Male
  • Papaverine (pharmacology)
  • Penile Erection (drug effects, physiology)
  • Phosphodiesterase Inhibitors (pharmacology)
  • Rats
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: